Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SHARON HERMES GIORDANO and LARISSA ALEJANDRA MEYER.
SHARON HERMES GIORDANO
Connection Strength
5.227
LARISSA ALEJANDRA MEYER
  1. Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol. 2018 09; 150(3):451-459.
    View in: PubMed
    Score: 0.638
  2. Healthcare Costs in the United States by Demographic Characteristics and Comorbidity Status. Value Health. 2024 Nov 10.
    View in: PubMed
    Score: 0.248
  3. Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021. Gynecol Oncol. 2024 Nov; 190:255-261.
    View in: PubMed
    Score: 0.245
  4. Cost of ovarian cancer by the phase of care in the United States. Am J Obstet Gynecol. 2024 Aug 17.
    View in: PubMed
    Score: 0.244
  5. Determination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecol Oncol. 2024 06; 185:101-107.
    View in: PubMed
    Score: 0.236
  6. Secondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer. 2023 05 01; 33(5):749-754.
    View in: PubMed
    Score: 0.223
  7. Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis. Ann Surg Oncol. 2023 Mar; 30(3):1508-1519.
    View in: PubMed
    Score: 0.215
  8. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer. 2022 09 06; 32(9):1153-1163.
    View in: PubMed
    Score: 0.213
  9. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer. 2022 07 04; 32(7):899-905.
    View in: PubMed
    Score: 0.211
  10. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol. 2022 09; 227(3):482.e1-482.e15.
    View in: PubMed
    Score: 0.208
  11. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. JCO Clin Cancer Inform. 2022 03; 6:e2100187.
    View in: PubMed
    Score: 0.206
  12. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer. 2021 Nov 15; 127(22):4151-4160.
    View in: PubMed
    Score: 0.198
  13. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11.
    View in: PubMed
    Score: 0.191
  14. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020 08; 30(8):1195-1202.
    View in: PubMed
    Score: 0.183
  15. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer. 2020 02; 30(2):187-192.
    View in: PubMed
    Score: 0.176
  16. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019 11; 221(5):474.e1-474.e11.
    View in: PubMed
    Score: 0.170
  17. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol. 2019 08; 221(2):136.e1-136.e9.
    View in: PubMed
    Score: 0.168
  18. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol. 2019 03; 152(3):439-444.
    View in: PubMed
    Score: 0.167
  19. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol. 2019 03; 152(3):452-458.
    View in: PubMed
    Score: 0.167
  20. Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol. 2018 11; 151(2):269-274.
    View in: PubMed
    Score: 0.162
  21. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol. 2018 07; 132(1):52-58.
    View in: PubMed
    Score: 0.160
  22. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017 Jun 01; 35(16):1829-1835.
    View in: PubMed
    Score: 0.146
  23. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 04; 145(1):55-60.
    View in: PubMed
    Score: 0.145
  24. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78.
    View in: PubMed
    Score: 0.050
  25. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol. 2021 10 01; 138(4):565-573.
    View in: PubMed
    Score: 0.050
  26. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118.
    View in: PubMed
    Score: 0.049
  27. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol. 2021 01; 160(1):199-205.
    View in: PubMed
    Score: 0.047
  28. Variation in resource utilization associated with the surgical management of ovarian cancer. Gynecol Oncol. 2019 03; 152(3):587-593.
    View in: PubMed
    Score: 0.041
  29. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. 2017 09; 27(7):1350-1359.
    View in: PubMed
    Score: 0.038
  30. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):260-7.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.